Sustained delivery of transforming growth factor beta three enhances tendon-to-bone healing in a rat model

Cionne N. Manning, Hyun-Min Mike Kim, Shelly Sakiyama-Elbert, Leesa M. Galatz, Necat Havlioglu, Stavros Thomopoulos

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Despite advances in surgical technique, rotator cuff repairs are plagued by a high rate of failure. This failure rate is in part due to poor tendon-to-bone healing; rather than regeneration of a fibrocartilaginous attachment, the repair is filled with disorganized fibrovascular (scar) tissue. Transforming growth factor beta 3 (TGF-β3) has been implicated in fetal development and scarless fetal healing and, thus, exogenous addition of TGF-β3 may enhance tendon-to-bone healing. We hypothesized that: TGF-β3 could be released in a controlled manner using a heparin/fibrin-based delivery system (HBDS); and delivery of TGF-β3 at the healing tendon-to-bone insertion would lead to improvements in biomechanical properties compared to untreated controls. After demonstrating that the release kinetics of TGF-β3 could be controlled using a HBDS in vitro, matrices were incorporated at the repaired supraspinatus tendon-to-bone insertions of rats. Animals were sacrificed at 14-56 days. Repaired insertions were assessed using histology (for inflammation, vascularity, and cell proliferation) and biomechanics (for structural and mechanical properties). TGF-β3 treatment in vivo accelerated the healing process, with increases in inflammation, cellularity, vascularity, and cell proliferation at the early timepoints. Moreover, sustained delivery of TGF-β3 to the healing tendon-to-bone insertion led to significant improvements in structural properties at 28 days and in material properties at 56 days compared to controls. We concluded that TGF-β3 delivered at a sustained rate using a HBDS enhanced tendon-to-bone healing in a rat model.

Original languageEnglish (US)
Pages (from-to)1099-1105
Number of pages7
JournalJournal of Orthopaedic Research
Volume29
Issue number7
DOIs
StatePublished - Jul 1 2011

Fingerprint

Transforming Growth Factor beta
Tendons
Bone and Bones
Fibrin
Heparin
Rotator Cuff
Cell Proliferation
Inflammation
Fetal Development
Biomechanical Phenomena
Cicatrix
Regeneration
Histology

All Science Journal Classification (ASJC) codes

  • Orthopedics and Sports Medicine

Cite this

Manning, Cionne N. ; Kim, Hyun-Min Mike ; Sakiyama-Elbert, Shelly ; Galatz, Leesa M. ; Havlioglu, Necat ; Thomopoulos, Stavros. / Sustained delivery of transforming growth factor beta three enhances tendon-to-bone healing in a rat model. In: Journal of Orthopaedic Research. 2011 ; Vol. 29, No. 7. pp. 1099-1105.
@article{33a3ef3ef5d14b18a1ca52dc59a851de,
title = "Sustained delivery of transforming growth factor beta three enhances tendon-to-bone healing in a rat model",
abstract = "Despite advances in surgical technique, rotator cuff repairs are plagued by a high rate of failure. This failure rate is in part due to poor tendon-to-bone healing; rather than regeneration of a fibrocartilaginous attachment, the repair is filled with disorganized fibrovascular (scar) tissue. Transforming growth factor beta 3 (TGF-β3) has been implicated in fetal development and scarless fetal healing and, thus, exogenous addition of TGF-β3 may enhance tendon-to-bone healing. We hypothesized that: TGF-β3 could be released in a controlled manner using a heparin/fibrin-based delivery system (HBDS); and delivery of TGF-β3 at the healing tendon-to-bone insertion would lead to improvements in biomechanical properties compared to untreated controls. After demonstrating that the release kinetics of TGF-β3 could be controlled using a HBDS in vitro, matrices were incorporated at the repaired supraspinatus tendon-to-bone insertions of rats. Animals were sacrificed at 14-56 days. Repaired insertions were assessed using histology (for inflammation, vascularity, and cell proliferation) and biomechanics (for structural and mechanical properties). TGF-β3 treatment in vivo accelerated the healing process, with increases in inflammation, cellularity, vascularity, and cell proliferation at the early timepoints. Moreover, sustained delivery of TGF-β3 to the healing tendon-to-bone insertion led to significant improvements in structural properties at 28 days and in material properties at 56 days compared to controls. We concluded that TGF-β3 delivered at a sustained rate using a HBDS enhanced tendon-to-bone healing in a rat model.",
author = "Manning, {Cionne N.} and Kim, {Hyun-Min Mike} and Shelly Sakiyama-Elbert and Galatz, {Leesa M.} and Necat Havlioglu and Stavros Thomopoulos",
year = "2011",
month = "7",
day = "1",
doi = "10.1002/jor.21301",
language = "English (US)",
volume = "29",
pages = "1099--1105",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

Sustained delivery of transforming growth factor beta three enhances tendon-to-bone healing in a rat model. / Manning, Cionne N.; Kim, Hyun-Min Mike; Sakiyama-Elbert, Shelly; Galatz, Leesa M.; Havlioglu, Necat; Thomopoulos, Stavros.

In: Journal of Orthopaedic Research, Vol. 29, No. 7, 01.07.2011, p. 1099-1105.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sustained delivery of transforming growth factor beta three enhances tendon-to-bone healing in a rat model

AU - Manning, Cionne N.

AU - Kim, Hyun-Min Mike

AU - Sakiyama-Elbert, Shelly

AU - Galatz, Leesa M.

AU - Havlioglu, Necat

AU - Thomopoulos, Stavros

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Despite advances in surgical technique, rotator cuff repairs are plagued by a high rate of failure. This failure rate is in part due to poor tendon-to-bone healing; rather than regeneration of a fibrocartilaginous attachment, the repair is filled with disorganized fibrovascular (scar) tissue. Transforming growth factor beta 3 (TGF-β3) has been implicated in fetal development and scarless fetal healing and, thus, exogenous addition of TGF-β3 may enhance tendon-to-bone healing. We hypothesized that: TGF-β3 could be released in a controlled manner using a heparin/fibrin-based delivery system (HBDS); and delivery of TGF-β3 at the healing tendon-to-bone insertion would lead to improvements in biomechanical properties compared to untreated controls. After demonstrating that the release kinetics of TGF-β3 could be controlled using a HBDS in vitro, matrices were incorporated at the repaired supraspinatus tendon-to-bone insertions of rats. Animals were sacrificed at 14-56 days. Repaired insertions were assessed using histology (for inflammation, vascularity, and cell proliferation) and biomechanics (for structural and mechanical properties). TGF-β3 treatment in vivo accelerated the healing process, with increases in inflammation, cellularity, vascularity, and cell proliferation at the early timepoints. Moreover, sustained delivery of TGF-β3 to the healing tendon-to-bone insertion led to significant improvements in structural properties at 28 days and in material properties at 56 days compared to controls. We concluded that TGF-β3 delivered at a sustained rate using a HBDS enhanced tendon-to-bone healing in a rat model.

AB - Despite advances in surgical technique, rotator cuff repairs are plagued by a high rate of failure. This failure rate is in part due to poor tendon-to-bone healing; rather than regeneration of a fibrocartilaginous attachment, the repair is filled with disorganized fibrovascular (scar) tissue. Transforming growth factor beta 3 (TGF-β3) has been implicated in fetal development and scarless fetal healing and, thus, exogenous addition of TGF-β3 may enhance tendon-to-bone healing. We hypothesized that: TGF-β3 could be released in a controlled manner using a heparin/fibrin-based delivery system (HBDS); and delivery of TGF-β3 at the healing tendon-to-bone insertion would lead to improvements in biomechanical properties compared to untreated controls. After demonstrating that the release kinetics of TGF-β3 could be controlled using a HBDS in vitro, matrices were incorporated at the repaired supraspinatus tendon-to-bone insertions of rats. Animals were sacrificed at 14-56 days. Repaired insertions were assessed using histology (for inflammation, vascularity, and cell proliferation) and biomechanics (for structural and mechanical properties). TGF-β3 treatment in vivo accelerated the healing process, with increases in inflammation, cellularity, vascularity, and cell proliferation at the early timepoints. Moreover, sustained delivery of TGF-β3 to the healing tendon-to-bone insertion led to significant improvements in structural properties at 28 days and in material properties at 56 days compared to controls. We concluded that TGF-β3 delivered at a sustained rate using a HBDS enhanced tendon-to-bone healing in a rat model.

UR - http://www.scopus.com/inward/record.url?scp=79955887598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955887598&partnerID=8YFLogxK

U2 - 10.1002/jor.21301

DO - 10.1002/jor.21301

M3 - Article

C2 - 21246611

AN - SCOPUS:79955887598

VL - 29

SP - 1099

EP - 1105

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 7

ER -